The Market Reports

Synopsis

The global market for MHC-Peptide Tetramer was estimated to be worth US$ 194 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.

An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research.

Increased focus on cancer immunotherapy and adoptive T cell therapies is driving demand for MHC tetramers to study antigen-specific T cell responses.

This report aims to provide a comprehensive presentation of the global market for MHC-Peptide Tetramer, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of MHC-Peptide Tetramer by region & country, by Type, and by Application.

The MHC-Peptide Tetramer market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MHC-Peptide Tetramer.

Market Segmentation
By Company

• BioLegend (Revvity)
• MBL Life Science (JSR Corporation)
• ImmunAware
• ProImmune
• MedChemExpress (MCE)
• Creative Biolabs
• WuXi AppTec
• KACTUS
• Creative Biosciences
• ACROBiosystems
• ChemPartner

Segment by Type

• MHC-I
• MHC-II

Segment by Application

• Infectious Disease Research
• Cancer Immunology
• Other

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.